Baxter International Inc stock page - price, fundamentals, dividends - iOCharts

Ticker
BAX

Price
72.60
Stock movement up
+0.48 (0.67%)
Company name
Baxter International Inc
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
36.56B
Ent value
57.86B
Price/Sales
2.70
Price/Book
4.01
Div yield
1.60%
Div growth
16.53%
Growth years
5
FCF payout
40.64%
Trailing P/E
34.58
Forward P/E
15.22
PEG
3.58
EPS growth
13.20%
1 year return
-12.49%
3 year return
-1.21%
5 year return
4.93%
10 year return
9.64%
Last updated: 2022-05-19

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.16
Dividend yield1.60%
Payout frequencyQuarterly
Maximum yield1.61%
Average yield1.17%
Minimum yield0.89%
Discount to avg yield26.95%
Upside potential36.90%
Yield as % of max yield99.17%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.60%
Current yield distribution0.24%
Yield at 100% (Min)0.89%
Yield at 90%1.00%
Yield at 80%1.02%
Yield at 50% (Median)1.13%
Yield at 20%1.32%
Yield at 10%1.40%
Yield at 0% (Max)1.61%

Dividend per share

Loading...
Dividend per share data
Years of growth5 years
CCC statusDividend Challenger
Dividend per share1.16
Payout frequencyQuarterly
Ex-div date2 Jun 2022
EPS (TTM)2.08
EPS (1y forward)4.77
EPS growth (5y)13.20%
EPS growth (5y forward)9.67%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BAXS&P500
DGR MR3.57%-16.52%
DGR TTM11.33%4.37%
DGR 3 years14.12%3.88%
DGR 5 years16.53%4.73%
DGR 10 years4.67%8.30%
DGR 15 years8.57%5.82%
Time since last change announced17 days
EPS growth (5y)13.20%
EPS growth (5y forward)9.67%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM51.56%40.64%
Average--
Forward24.32%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E34.58
Price to OCF17.81
Price to FCF27.26
Price to EBITDA14.53
EV to EBITDA23.00

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.70
Price to Book4.01
EV to Sales4.27

FINANCIALS

Per share

Loading...
Per share data
Current share count503.53M
EPS (TTM)2.08
FCF per share (TTM)2.65

Income statement

Loading...
Income statement data
Revenue (TTM)13.54B
Gross profit (TTM)5.31B
Operating income (TTM)1.30B
Net income (TTM)1.06B
EPS (TTM)2.08
EPS (1y forward)4.77

Margins

Loading...
Margins data
Gross margin (TTM)39.19%
Operating margin (TTM)9.62%
Profit margin (TTM)7.80%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.29B
Net receivables2.47B
Total current assets8.17B
Goodwill9.82B
Intangible assets7.69B
Property, plant and equipment0.00
Total assets32.72B
Accounts payable1.22B
Short/Current long term debt17.68B
Total current liabilities3.89B
Total liabilities23.60B
Shareholder's equity9.12B
Net tangible assets-8.43B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)2.05B
Capital expenditures (TTM)712.00M
Free cash flow (TTM)1.34B
Dividends paid (TTM)545.00M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity11.59%
Return on Assets3.23%
Return on Invested Capital11.09%
Cash Return on Invested Capital14.07%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open71.55
Daily high72.70
Daily low71.16
Daily Volume2.50M
All-time high94.14
1y analyst estimate91.21
Beta0.60
EPS (TTM)2.08
Dividend per share1.16
Ex-div date2 Jun 2022
Next earnings date27 Jul 2022

Downside potential

Loading...
Downside potential data
BAXS&P500
Current price drop from All-time high-22.88%-18.47%
Highest price drop-68.86%-56.47%
Date of highest drop1 Apr 20039 Mar 2009
Avg drop from high-15.95%-11.34%
Avg time to new high25 days12 days
Max time to new high1406 days1805 days
COMPANY DETAILS
BAX (Baxter International Inc) company logo
Marketcap
36.56B
Marketcap category
Large-cap
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Employees
60000
Investor relations
SEC filings
CEO
Jose Almeida
Country
USA
City
Deerfield
Stock type
Common stock
CCC status
Dividend Challenger
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
DEERFIELD, Ill., May 10, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host an investor conference on Wednesday, May 25, 2022 in Glenview, Ill. Chairman and CEO Joe Almeida...
May 10, 2022
Adding defensive healthcare stocks can be a great way to ride out continued volatility in the market. AbbVie (ABBV): Investors are overreacting to this venerable big pharma company’s recent earnings r...
May 6, 2022
DEERFIELD, Ill., May 03, 2022--Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced an increase in the company’s quarterly cash dividend to a rate of $0.29 per share...
May 3, 2022
Baxter's (BAX) first-quarter results reflect robust performance across four of its business units.
April 28, 2022
Baxter (BAX) delivered earnings and revenue surprises of 16.25% and 1.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
April 28, 2022
DEERFIELD, Ill., April 28, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2022.
April 28, 2022
If you're an income investor, you always want to keep an eye on falling dividend stocks. A couple of dividend stocks that currently are down and trading near their 52-week lows include Baxter Interna...
April 27, 2022
The MedTech companies' Q1 results are likely to reflect solid rebound in base business sales. Let's see how ABMD, SYK, BAX and DXCM are poised ahead of their earnings releases.
April 27, 2022
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
April 21, 2022
Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio and regulatory clearances.
April 21, 2022
Next page